20th-May-2013 16:43Source: BSE

Dr Reddys Labs- Fixes Book Closure for Dividend & AGM

Dr Reddys Laboratories Ltd has informed BSE that the Register of Members & Share Transfer Books of the Company will remain closed from July 16, 2013 to July 19, 2013 (both days inclusive) for the purp...

16th-May-2013 16:00Source: NSE

Dr. Reddy's Laboratories Limited

Life Insurance Corporation of India has submitted to the Exchange a copy of disclosure under SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 and under SEBI (Prohibition of Insid...

15th-May-2013 20:55Source: NSE

Dr. Reddy's Laboratories Limited

Dr. Reddy's Laboratories Limited has informed the Exchange that the Nomination, Governance & Compensation Committee of the Board of Directors of the Company in their meeting held on May 13, 2013 has g...

15th-May-2013 18:02Source: BSE

Dr Reddys Labs- Grant of Stock Options

Dr Reddys Laboratories Ltd has informed BSE that the Nomination, Governance & Compensation Committee of the Board of Directors of the Company in their meeting held on May 13, 2013 has granted 261,650 ...

14th-May-2013 15:02Source: NSE

Dr. Reddy's Laboratories Limited

Dr. Reddy's Laboratories Limited has informed the Exchange regarding the standalone Results for the quarter ended on 31-MAR-2013 as follows: Net Sales of Rs. 216090 lacs for the quarter ending on 31-M...

14th-May-2013 14:11Source: BSE

Dr Reddys Labs- Board recommends Final Dividend

Dr Reddys Laboratories Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 14, 2013, inter alia, has recommended a final dividend of Rs. 15/- (300%) per equity s...

13th-May-2013 15:14Source: BSE

Dr Reddys Labs- Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011

Life Insurance Corporation of India has submitted the disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011

9th-Apr-2013 20:52Source: NSE

Dr. Reddy's Laboratories Limited

Dr. Reddy's Laboratories Limited has informed the Exchange regarding a Press Release dated April 09, 2013 titled "Dr. Reddy s announces the relocation of their North America headquarters and establish...

8th-Apr-2013 19:51Source: BSE

Dr Reddys Labs- FY 13 results on May 14, 2013

Dr Reddys Labs has its Board of Directors meeting on May 14, 2013 to consider and approve the Audited Financial Results of the Company for the financial year ended March 31, 2013 and recommend dividen...

4th-Apr-2013 12:17Source: BSE

Dr Reddys Labs- Dr. Reddy's Announces the Launch of Zoledronic Acid Injection

Dr Reddys Laboratories Ltd has informed BSE regarding a Press Release dated April 04, 2013 titled "Dr. Reddy''s Announces the Launch of Zoledronic Acid Injection." Dr Reddys Laboratories has la...